Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: Clinicopathological features, efficacy, and factors affecting survival için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: Clinicopathological features, efficacy, and factors affecting survival | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Ekim 2024 | 0 |
| Kasım 2024 | 0 |
| Aralık 2024 | 0 |
| Ocak 2025 | 0 |
| Şubat 2025 | 0 |
| Mart 2025 | 0 |
| Nisan 2025 | 0 |
